Details for New Drug Application (NDA): 075634
✉ Email this page to a colleague
NDA 075634 describes ENALAPRILAT, which is a drug marketed by Chartwell Injectable, Dr Reddys, Hikma Farmaceutica, and Hospira, and is included in six NDAs. It is available from three suppliers. Additional details are available on the ENALAPRILAT profile page.
The generic ingredient in ENALAPRILAT is enalaprilat. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalaprilat profile page.
The generic ingredient in ENALAPRILAT is enalaprilat. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalaprilat profile page.
Summary for 075634
| Tradename: | ENALAPRILAT |
| Applicant: | Chartwell Injectable |
| Ingredient: | enalaprilat |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075634
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1.25MG/ML | ||||
| Approval Date: | Aug 22, 2000 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
